Novel protein-protein interaction inhibitor of Nrf2-Keap1 discovered by structure-based virtual screening

MedChemComm

Volumn 5, Issue 1, 2014, Pages 93-98

  Sun, Hao Peng ^a   Jiang, Zheng Yu ^a   Zhang, Ming Ye ^a   Lu, Meng Chen ^a   Yang, Ting Ting ^a   Pan, Yang ^a   Huang, Hao Ze ^a   Zhang, Xiao Jin ^a   You, Qi Dong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS AFFECTING PROTEIN METABOLISM; KELCH LIKE ECH ASSOCIATED PROTEIN 1; LH 601; PROTEIN INHIBITOR; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONCENTRATION RESPONSE; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; FLUORESCENCE POLARIZATION; LIGAND BINDING; MOLECULAR DOCKING; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

EID: 84890849400     PISSN: 20402503     EISSN: 20402511     Source Type: Journal    
DOI: 10.1039/c3md00240c     Document Type: Article

References (28)

1. T. Finkel N. J. Holbrook Oxidants, oxidative stress and the biology of ageing Nature 2000 408 6809 239 247
2. K. J. Barnham C. L. Masters A. I. Bush Neurodegenerative diseases and oxidative stress Nat. Rev. Drug Discovery 2004 3 3 205 214
3. C. C. Benz C. Yau Ageing, oxidative stress and cancer: paradigms in parallax Nat. Rev. Cancer 2008 8 11 875 879
4. C. Leeuwenburgh J. W. Heinecke Oxidative stress and antioxidants in exercise Curr. Med. Chem. 2001 8 7 829 838
5. R. Brigelius-Flohe L. Flohe Basic principles and emerging concepts in the redox control of transcription factors Antioxid. Redox Signaling 2011 15 8 2335 2381
6. P. Moi K. Chan I. Asunis A. Cao Y. W. Kan Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region Proc. Natl. Acad. Sci. U. S. A. 1994 91 21 9926 9930
7. K. Itoh K. Igarashi N. Hayashi M. Nishizawa M. Yamamoto Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins Mol. Cell. Biol. 1995 15 8 4184 4193
8. A. Martin-Montalvo J. M. Villalba P. Navas R. de Cabo NRF2, cancer and calorie restriction Oncogene 2011 30 5 505 520
9. T. W. Kensler N. Wakabayashi S. Biswal Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway Annu. Rev. Pharmacol. 2007 47 89 116
10. S. Magesh Y. Chen L. Hu Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents Med. Res. Rev. 2012 32 4 687 726
11. S. A. Reisman G. M. Chertow S. Hebbar N. D. Vaziri K. W. Ward C. J. Meyer Bardoxolone Methyl Decreases Megalin and Activates Nrf2 in the Kidney J. Am. Soc. Nephrol. 2012 23 10 1663 1673
12. R. A. Linker D. H. Lee S. Ryan A. M. van Dam R. Conrad P. Bista W. Zeng X. Hronowsky A. Buko S. Chollate G. Ellrichmann W. Bruck K. Dawson S. Goelz S. Wiese R. H. Scannevin M. Lukashev R. Gold Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway Brain 2011 134 3 678 692
13. W. Hur N. S. Gray Small molecule modulators of antioxidant response pathway Curr. Opin. Chem. Biol. 2011 15 1 162 173
14. L. Hu S. Magesh L. Chen L. Wang T. A. Lewis Y. Chen C. Khodier D. Inoyama L. J. Beamer T. J. Emge J. Shen J. E. Kerrigan A. N. Kong S. Dandapani M. Palmer S. L. Schreiber B. Munoz Discovery of a small-molecule inhibitor and cellular probe of Keap1-Nrf2 protein-protein interaction Bioorg. Med. Chem. Lett. 2013 23 10 3039 3043
15. D. Marcotte W. Zeng J.-C. Hus A. McKenzie C. Hession P. Jin C. Bergeron A. Lugovskoy I. Enyedy H. Cuervo D. Wang C. Atmanene D. Roecklin M. Vecchi V. Vivat J. Kraemer D. Winkler V. Hong J. Chao M. Lukashev L. Silvian Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism Bioorg. Med. Chem. 2013 21 14 4011 4019
16. M. McMahon N. Thomas K. Itoh M. Yamamoto J. D. Hayes Dimerization of Substrate Adaptors Can Facilitate Cullin-Mediated Ubiquitylation of Proteins by a Tethering, Mechanism J. Biol. Chem. 2006 281 34 24756
17. K. I. Tong Y. Katoh H. Kusunoki K. Itoh T. Tanaka M. Yamamoto Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model Mol. Cell. Biol. 2006 26 8 2887 2900
18. K. I. Tong A. Kobayashi F. Katsuoka M. Yamamoto Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism Biol. Chem. 2006 387 10-11 1311 1320
19. K. I. Tong B. Padmanabhan A. Kobayashi C. Shang Y. Hirotsu S. Yokoyama M. Yamamoto Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response Mol. Cell. Biol. 2007 27 21 7511 7521
20. B. Padmanabhan K. I. Tong T. Ohta Y. Nakamura M. Scharlock M. Ohtsuji M.-I. Kang A. Kobayashi S. Yokoyama M. Yamamoto Structural Basis for Defects of Keap1 Activity Provoked by Its Point Mutations in Lung Cancer Mol. Cell 2006 21 5 689 700
21. S.-C. Lo X. Li M. T. Henzl L. J. Beamer M. Hannink Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling EMBO J. 2006 25 15 3605 3617
22. R. Hancock H. C. Bertrand T. Tsujita S. Naz A. El-Bakry J. Laoruchupong J. D. Hayes G. Wells Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction Free Radical Biol. Med. 2012 52 2 444 451
23. R. Steel J. Cowan E. Payerne M. A. O'Connell M. Searcey Anti-Inflammatory Effect of a Cell-Penetrating Peptide Targeting the Nrf2-Keap1 Interaction ACS Med. Chem. Lett. 2012 3 5 407 410
24. R. Hancock M. Schaap H. Pfister G. Wells Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction with improved binding and cellular activity Org. Biomol. Chem. 2013 11 21 3553 3557
25. Z.-Y. Jiang H.-X. Chu M.-Y. Xi T.-T. Yang J.-M. Jia J.-J. Huang X.-K. Guo X.-J. Zhang Q.-D. You H.-P. Sun Insight into the Intermolecular Recognition Mechanism between Keap1 and IKKβ Combining Homology Modelling, Protein-Protein Docking, Molecular Dynamics Simulations and Virtual Alanine Mutation PLoS One 2013 8 9 e75076
26. A. R. Leach V. J. Gillet R. A. Lewis R. Taylor Three-dimensional pharmacophore methods in drug discovery J. Med. Chem. 2010 53 2 539 558
27. F. Caporuscio A. Tafi Pharmacophore Modelling: A Forty Year Old Approach and its Modern Synergies Curr. Med. Chem. 2011 18 17 2543 2553
28. D. Inoyama Y. Chen X. Huang L. J. Beamer A. N. Kong L. Hu Optimization of fluorescently labeled Nrf2 peptide probes and the development of a fluorescence polarization assay for the discovery of inhibitors of Keap1-Nrf2 interaction J. Biomol. Screening 2012 17 4 435 447